Comparing G-Computation, Propensity Score-Based Weighting, and Targeted Maximum Likelihood Estimation for Analyzing Externally Controlled Trials with an Unmeasured Confounder: A Simulation Study

Author(s)

Ren J1, Cislo P2, Cappelleri JC3, Hlavacek P2, DiBonaventura M2
1Pfizer Inc, Collegeville, PA, USA, 2Pfizer Inc, New York, NY, USA, 3Pfizer Inc., Groton, CT, USA

Presentation Documents

OBJECTIVES: In orphan and rare diseases, single-arm trials are common given the impracticability, if not impossibility, of randomized controlled trials. In these settings, an external control (EC) can be employed to compare against the single-arm trial to estimate treatment effects, though minimizing potential biases to interpret these effects is critical. We sought to compare different methods for causal inference in simulated data sets with measured (included from the model) and unmeasured (excluded) confounders.

METHODS: In the simulated data, three types of outcomes (continuous, binary, and time-to-event) were compared between trial and EC arms. Two measured baseline covariates (confounders) were unbalanced between the two arms. For each outcome, the two scenarios for relationship between unmeasured confounder and observed variables were: A) directly associated with one baseline covariate and the outcome; and B) directly associated with one baseline covariate, the outcome, and treatment assignment. In 3,000 random samples (100 or 200 patients per sample), we used g-computation, propensity score-based weighting, and targeted maximum likelihood estimation (TMLE) to estimate treatment effects based on observed outcomes and measured covariates.

RESULTS: In scenario A, the average estimates from all proposed methods were similar to the true effect (e.g. 1.14 to 1.19 vs 1.15 for the binary outcome), but g-computation had the smallest mean squared error (MSE), as well as a reasonable coverage (0.91-0.94) as measured by 95% confidence interval in different settings. In scenario B, most of results were similar with those in scenario A, except in one setting of continuous outcome where the estimates were more discrepant from the true effect.

CONCLUSIONS: Treatment effects estimated by g-computation, propensity score-based weighting, and TMLE appear to be reasonable for EC trials, even if confounders are not completely measured. Of the proposed approaches, evidence suggests that g-computation is a preferable approach producing relatively unbiased estimates.

Conference/Value in Health Info

2022-05, ISPOR 2022, Washington, DC, USA

Value in Health, Volume 25, Issue 6, S1 (June 2022)

Acceptance Code

P29

Topic

Clinical Outcomes, Methodological & Statistical Research

Topic Subcategory

Comparative Effectiveness or Efficacy, Confounding, Selection Bias Correction, Causal Inference

Disease

Oncology, rare-and-orphan-diseases

Explore Related HEOR by Topic


Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×